HealthPhoto: ABP NewsPersonalised Cancer Vaccine Reduces Risk by 42% in Trials
A personalised cancer vaccine has shown promising results in clinical trials, reducing the risk of death from skin cancer by up to 42%. This new treatment approach, tailored to the patient's condition, aims to eliminate tumors effectively. It marks a significant advancement in lung and skin cancer therapies, offering renewed hope for patients.
ABP News·



